With monotherapy, lamotrigine has relatively few side-effects and generally doesn't lead to toxicity. However, clearance is altered by several other compounds and combination therapy with other anticonvulsant drugs can have a substantial effect on the clearance of this drug. Possible toxicity may be observed at concentrations of > or + 20 ug/mL.
Trough concentrations are most accurate and recommended for therapeutic drug monitoring. Preferably obtained just before the next dose.